Skip to main content
OpenTrials

Clinical trial condition

Female Urogenital Diseases

Explore clinical trials studying Female Urogenital Diseases. Study availability and eligibility vary by location and protocol.

21,977 public trials 3,763 recruiting studies
Refine in advanced search Browse all conditions

Female Urogenital Diseases trial results

Recruiting

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

NCT07216105

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +48 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
  • Thomas Jefferson University, Sidney Kimmel Cancer Center Philadelphia, Pennsylvania, United States
  • M. D. Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

NCT07159841

Conditions
Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +17 more
Locations
  • UCSF Ron Conway Gateway Medical Building San Francisco, California, United States
  • Boston's Children's Hospital Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View all 48 locations
View Trial Details
Recruiting

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

NCT04981509

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Emory Saint Joseph's Hospital Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Recruiting

KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)

NCT07232602

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • UCSF Medical Center at Mission Bay ( Site 5044) San Francisco, California, United States
  • University of Chicago Medical Center ( Site 5037) Chicago, Illinois, United States
  • Cleveland Clinic Taussig Cancer ( Site 5036) Cleveland, Ohio, United States
  • Huntsman Cancer Institute ( Site 5041) Salt Lake City, Utah, United States
View all 16 locations
View Trial Details
Recruiting

Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus

NCT06593392

Conditions
Chronic Disease, Chronic Kidney Diseases, Disease Attributes, +15 more
Locations
  • Sichuan University-West China Second University Hospital Chengdu, China
  • The First Affiliated Hospital, Sun Yat-sen University Guangzhou, China
  • Guangzhou Women and Children's Medical Center Guangzhou, China
  • The Children's Hospital Zhejiang University School of Medicine Hangzhou, China
View all 17 locations
View Trial Details

Related conditions